Inactive Instrument

Celsius Holdings, Inc. Share Price OTC Bulletin Board

Equities

CELH

US15118V2079

Non-Alcoholic Beverages

Real-time Estimate Cboe BZX 19:04:32 29/04/2024 BST 5-day change 1st Jan Change
73.86 USD 0.00% Intraday chart for Celsius Holdings, Inc. 0.00% 0.00%
Sales 2024 * 1.88B 149B Sales 2025 * 2.48B 198B Capitalization 17.05B 1,357B
Net income 2024 * 259M 20.62B Net income 2025 * 364M 28.97B EV / Sales 2024 * 9.02 x
Net cash position 2024 * 136M 10.85B Net cash position 2025 * 380M 30.22B EV / Sales 2025 * 6.71 x
P/E ratio 2024 *
66.4 x
P/E ratio 2025 *
47.4 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 44.8%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 44 31/12/11
Director of Finance/CFO 43 17/04/22
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 52 18/08/21
Director/Board Member 56 18/08/21
Director/Board Member 66 31/03/16
More insiders
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
More about the company